Metformin in Type 2 Diabetes: Evidence for its Beneficial Effects on Frailty and Sarcopenia.
Curr Diabetes Rev
; 20(3): e270723219177, 2024.
Article
em En
| MEDLINE
| ID: mdl-37497698
ABSTRACT
This narrative review aimed to discuss the potential interplay among frailty syndrome, sarcopenia and metformin in type 2 diabetes mellitus (T2DM). There is emerging evidence on the potential protective role of metformin on both frailty and sarcopenia. However, results are not always consistent. Thus, further research is needed to provide a definitive answer on any role of metformin in improving frailty and/or sarcopenia in T2DM.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Diabetes Mellitus Tipo 2
/
Sarcopenia
/
Fragilidade
/
Metformina
Limite:
Aged
/
Humans
Idioma:
En
Revista:
Curr Diabetes Rev
Ano de publicação:
2024
Tipo de documento:
Article